dualyx
Technologiepark-Zwijnaarde 94
9052 Gent
BE
dualyx
Foundation date
21/11/2019
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Proteins
- #Other - AgBio
- #Other - Cosmetics
- #Other - Environmental
- #Other - Food
- #Other - Industrial Biotechnology
- #Other - Nutraceuticals
- #Other - Veterinary
- #Pharma - Cell therapy
- #Pharma - Gene therapy
- #Professional Services - IT services
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Musculoskeletal system and connective tissue
- #Respiratory system
- #Skin and subcutaneous tissue
dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.
Upcoming events
All events-
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB -
1212 '22
Type 2 Immunity in Homeostasis and Disease (2nd edition)
Event by: VIB -
2911 '22
BioFIT 2022
Event by: Eurasanté
Latest news
More news-
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
12 hours ago
Read more
-
Indigo Diabetes announces first participant enrolled in the SHINE clinical trial
Thursday September 29th 2022
Read more
-
FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome
Tuesday September 27th 2022
Read more